APOLIPOPROTEIN-E TO APOLIPOPROTEIN-B RATIO - A MARKER FOR TYPE-III HYPERLIPOPROTEINEMIA

被引:0
作者
MARZ, W
FEUSSNER, G
SIEKMEIER, R
DONNERHAK, B
SCHAAF, L
RUZICKA, V
GROSS, W
机构
[1] UNIV HEIDELBERG,INNERE MED ABT 1,MED KLIN,W-6900 HEIDELBERG,GERMANY
[2] UNIV FRANKFURT,ENDOKRINOL ABT,ZENTRUM INNEREN MED,W-6000 FRANKFURT 1,GERMANY
来源
EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY | 1993年 / 31卷 / 11期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoproteins B and E were determined in 40 patients with type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia) and in 48 patients with other types of hyperlipoproteinaemia matched for cholesterol and triacylglycerols. In type III patients, apolipoprotein E was increased and apolipoprotein B was lower than in other types of hyperlipoproteinaemia. The apolipoprotein E to apolipoprotein B ratio almost completely discriminated between type III and other types of hyperlipoproteinaemia. Assuming a cut-off value of 0.09 for the apolipoprotein E to apolipoprotein B ratio, diagnostic sensitivity was 95% and specificity was 88%. It is concluded that the apolipoprotein E to apolipoprotein B ratio represents the first-line screening quantity of choice for the identification of patients with type III hyperlipoproteinaemia in the clinical laboratory.
引用
收藏
页码:743 / 747
页数:5
相关论文
共 50 条
[21]   EFFECTS OF ESTROGEN THERAPY ON APOLIPOPROTEIN E IN TYPE-III HYPERLIPOPROTEINEMIA [J].
FALKO, JM ;
SCHONFELD, G ;
WITZTUM, JL ;
KOLAR, J ;
WEIDMAN, SW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (11) :1171-1177
[22]   INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON PLASMA-LIPID AND APOLIPOPROTEIN LEVELS, AND CLINICAL CHARACTERISTICS OF TYPE-III HYPERLIPOPROTEINEMIA DUE TO APOLIPOPROTEIN-E PHENOTYPE-E2/2 IN JAPAN [J].
KOBORI, S ;
NAKAMURA, N ;
UZAWA, H ;
SHICHIRI, M .
ATHEROSCLEROSIS, 1988, 69 (01) :81-88
[23]   SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEIN-E PHENOTYPES IN RELATIVES OF PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA [J].
STUYT, PMJ ;
DEMACKER, PNM ;
VANTLAAR, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (03) :219-226
[24]   APOLIPOPROTEIN E2-CHRISTCHURCH (136 ARG -] SER) - NEW VARIANT OF HUMAN APOLIPOPROTEIN-E IN A PATIENT WITH TYPE-III HYPERLIPOPROTEINEMIA [J].
WARDELL, MR ;
BRENNAN, SO ;
JANUS, ED ;
FRASER, R ;
CARRELL, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (02) :483-490
[25]   TYPE-III HYPERLIPOPROTEINEMIA ASSOCIATED WITH PLASMA APOLIPOPROTEIN E ABSENCE [J].
GHISELLI, G ;
SCHAEFER, EJ ;
BREWER, HB .
ARTERIOSCLEROSIS, 1981, 1 (05) :A377-A377
[26]   TYPE-III HYPERLIPOPROTEINEMIA ASSOCIATED WITH APOLIPOPROTEIN-E PHENOTYPE-E3/3 - STRUCTURE AND GENETICS OF AN APOLIPOPROTEIN-E3 VARIANT [J].
RALL, SC ;
NEWHOUSE, YM ;
CLARKE, HRG ;
WEISGRABER, KH ;
MCCARTHY, BJ ;
MAHLEY, RW ;
BERSOT, TP .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1095-1101
[27]   APOLIPOPROTEIN-E AND APOLIPOPROTEIN-B CONCENTRATIONS IN CEREBROSPINAL-FLUID [J].
CARLSSON, J ;
ARMSTRONG, VW ;
REIBER, H ;
SEIDEL, D .
CLINICAL CHEMISTRY, 1990, 36 (06) :967-968
[30]   ASSOCIATION OF APOLIPOPROTEIN-E BUT NOT APOLIPOPROTEIN-B WITH ALZHEIMERS-DISEASE [J].
PODUSLO, SE ;
RIGGS, D ;
SCHWANKHAUS, J ;
OSBORNE, A ;
CRAWFORD, F ;
MULLAN, M .
HUMAN GENETICS, 1995, 96 (05) :597-600